Drugs / Povidone
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 42 trials | ||||||
| Phase 4 | NCT02752763 | Oct 2015 → Mar 2016 | dry eye syndrome | Niğde State Hospital | Completed | No outcome recorded |
| Phase 4 | NCT00135824 | Mar → May 2004 | — | Novartis | Completed | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT05287425 Comparator | Aug 2019 → Aug 2023 | — | Medical University of Vienna | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Povidone | “Refresh single dose(polyvinyl Alcohol + Povidone)” NCT02752763 ↗ |
| Known as | Povidone K25 | “Povidone K25 eye drops (povidone)” NCT00135824 ↗ |
| Route | Topical | “Povidone K25 eye drops (povidone)” NCT00135824 ↗ |